NutraShure

NutraShure · Ingredient Intelligence

The Microbiome‑Independent Future

A field report from Probiota Americas 2026. Six signals on where gut-health formulation is heading — and what each one means for the products you build next.

6 Formulation Signals Probiota Americas 2026 Free Field Report

If you formulate, regulate, or invest in gut health, Probiota Americas 2026 set a clear direction: the category is moving from live bacteria to measured biological effect. Butyrate, the gut virome, GLP-1, and culturomics all landed with real traction — not as trends, but as mechanisms that formulators are already building around. This report captures six of the sharpest signals from the floor and the keynotes, with context on what each one means for your next product decision.

Inside the Report

What’s Inside — 6 Signals

1
Butyrate moves to center stage — and why postbiotics are redefining what “gut health” means
2
GLP-1 as the center of gravity — the gut as the organ where metabolic demand is decided
3
The gut-brain axis goes commercial — mood and cognition claims now backed by validated instruments
4
The personalization problem — culturomics data on how much a fiber’s benefit depends on the gut it lands in
5
Phages outnumber the probiotic — what the gut virome means for a live organism’s odds
6
The commercial reality — the market data behind where the shelf is actually moving

Free Download

Get the Field Report

Enter your details and the report is yours instantly. We’ll also send a copy to your inbox.

✓
Immediate PDF download
✓
Copy sent to your inbox
✓
Occasional ingredient briefings — unsubscribe anytime

Your details

Resources Lead Capture

We respect your privacy. Unsubscribe at any time.

BS

Questions, or want to talk through what this means for your formulation? I would love to discuss.

Brandon Sojka
Founder & CEO, NutraShure
info@nutrashure.com